If you invest passively in private equity funds as a limited partner, you have probably encountered a distribution notice, a quarterly report, or a capital call memo that references a NAV loan. These fund-level borrowing arrangements, secured by the net asset value of the fund's underlying assets, have moved from a niche corner of fund finance to a central feature of how many general partners manage liquidity, hold periods, and distributions.
NAV lending began in the mid-2000s. By 2022, NAV lending penetration exceeded 75% among private equity funds, and the NAV financing market is projected to reach $700 billion by 2030. Cumulative NAV lending volume surpassed $1 billion in 2017, and volume increased 142% from €330 million in 2023 to €800 million in 2024. These numbers reflect a market that is no longer experimental.
The driving forces are familiar to anyone watching private markets: slower exits, elongated hold periods, compressed M&A activity, and the need for interim liquidity in a down market. NAV loans have gained popularity as a tool during these challenging conditions, giving fund managers a way to generate distributions, support existing portfolio companies, or bridge timing gaps without forced asset sales. But the same tool that smooths cash flows for limited partners can also obscure performance, layer risk onto a portfolio, and shift alignment between general partners and limited partners.
This article is a practical diligence guide for accredited investors and qualified purchasers evaluating a fund that is using, or proposing to use, a NAV loan. It covers risk, alignment, reporting, and contractual protections. It is informational, not individualized legal or tax advice. LPs should review their limited partnership agreements, side letters, and consult counsel before consenting to new NAV based facilities.
Fund-Level Debt vs Company Leverage vs Subscription Lines
Before examining NAV facilities in detail, it helps to understand where they sit relative to the two other common forms of debt in a private equity fund structure.
Company-level leverage is debt incurred by each individual portfolio company, including LBO loans, unitranche financing, and mezzanine instruments. This debt is secured by the operating company's own assets and cash flows. In standard buyout funds, company-level debt is non-recourse to the fund and to LPs beyond their committed capital. The risk to LPs is indirect: if a portfolio company defaults, the equity value of that investment may be impaired or lost.
Subscription line financing (also called capital call lines) is short-term borrowing secured by uncalled LP capital commitments. Private equity firms use these early in the fund life to smooth capital calls, bridge acquisitions, or cover administrative needs. Lenders rely on LP commitments, not portfolio performance, as their security.
NAV loans are fund-level debt secured against equity interests, distribution rights, or partnership interests in the fund's portfolio assets. They typically appear later in the fund's life, after most capital is drawn and the portfolio is in its value creation or harvest phase. NAV loans should be included in fund leverage calculations alongside other forms of debt. Hybrid loans combine uncalled capital commitments and NAV loan structures, creating dual-collateral credit facilities that blur the line between subscription lines and NAV financing.
Why does this distinction matter? Because the collateral, repayment priority, and impact on performance metrics differ for each type. A subscription line secured by LP commitments is fundamentally different from a NAV facility secured by unrealized portfolio value. Confusing them, or ignoring NAV lending when evaluating fund investments, can lead to misreading both risk and return.
What Is a NAV Loan in Private Equity? Mechanics and Structures
A NAV loan works as follows: a lender advances capital to the fund or a special purpose vehicle (SPV) based on the net asset value (NAV) of the fund's portfolio assets. The lender takes a security interest in shares, partnership interests, or distribution rights. The advance is capped at a negotiated loan-to-value (LTV) ratio.
LTV parameters vary by structure and portfolio type:
- Senior secured lending typically has LTV ratios of 5% to 12%
- Unitranche loans have LTV ratios ranging from 10% to 20%
- Mezzanine financing can have LTV ratios above 25%
- Structured equity financing or preferred equity arrangements typically feature LTV ratios of 50% to 75%
These are negotiated ranges, not guarantees. LPs should verify actual LTV caps in term sheets and final agreements.
Common structures include senior secured NAV loans (clean security, highest priority), unitranche NAV lending (combining senior and subordinated tranches), and hybrid credit facilities that layer subscription and NAV based collateral. Collateral packages typically involve pledges over shares or fund interests in portfolio companies, security over distribution accounts, and cross-collateralization across a diversified pool of assets.
Maturities commonly run two to five years, often with extension rights. Mandatory prepayments are frequently tied to exit proceeds, and cash sweep mechanisms require a portion or all of excess cash from realizations to flow to NAV lenders before distributions reach LPs.
Buyout funds, infrastructure funds, real estate vehicles, and private credit strategies all use NAV facilities, though the risk dynamics differ. Funds with more mature portfolios, where most capital is deployed and the investment period is substantially complete, are more likely to employ NAV financing. This matters for LP risk assessment because the remaining collateral consists of the fund's portfolio investments, which secure the loan and generate the cash to repay it.
Use of Proceeds: What Is the NAV Loan Actually Funding?
The use of NAV facilities can be prudent or reckless depending on whether they fund approved needs like distributions, acquisitions, portfolio-company support, and bridging liquidity needs, or instead increase over-leverage, obscure transparency, rely on shaky valuation marks, create conflicts of interest, or distort performance metrics. LPs should insist on clarity before consenting and ask what guidance and safeguards govern the facility.
Portfolio-support uses include funding add-on acquisitions, providing rescue capital to support portfolio companies facing cash flow shortfalls, and bridging delays in M&A or IPO markets. NAV financing supports existing portfolio companies and can allow funds to avoid selling assets at discounts in slow exit markets. NAV loans can provide liquidity during slow exit markets and provide interim liquidity without sacrificing equity upside.
Liquidity-to-LPs uses involve financing cash distributions to limited partners. Funds can use NAV loans to fund distributions to limited partners, but such distributions do not necessarily represent realized gains. This distinction is critical and explored further below.
Other uses may include refinancing existing fund level debt, paying management fees or fund expenses, seeding continuation vehicles, or financing secondary purchases. Some of these overlap with legitimate portfolio rebalancing; others raise concerns about financial engineering.
Red-flag scenarios for LPs include borrowing mainly to hit DPI hurdles, paying carried interest from borrowed funds rather than realizations, or using the facility to mask underperformance and create artificial liquidity. Ask for a written use-of-proceeds schedule that commits the GP, in advance, to how funds will be applied.
Collateral, Recourse and Repayment Priority
NAV loans are typically secured by equity interests in portfolio companies, intercompany receivables, rights to distributions, and sometimes cash held in distribution or escrow accounts. The borrowing entity is usually the fund itself or an aggregator SPV that holds the relevant assets.
At the fund or SPV level, NAV lenders are senior. When realizations occur, the lender is repaid ahead of distributions to LPs. This repayment priority means that in a stressed scenario, exit proceeds flow first to debt service, then to fees, and only then to limited partners and the GP's carried interest.
LPs should examine whether lenders have recourse beyond the borrowing vehicle. Guarantees from feeder funds, parallel funds, or other affiliated vehicles can extend exposure in ways that are not obvious from a summary term sheet. Side letters between the GP and lender may contain obligations that affect other institutional investors in the structure.
Cross-collateralization changes the risk profile materially. When all eligible assets are pledged under a single facility, gains in strong portfolio companies may be swept to cover debt linked to weaker or slower assets. NAV loans can create interconnected vulnerabilities across collateralized assets, and collateral valuation challenges can lead to disputes and financial instability. This exposure means that a successful exit of one company does not necessarily translate into a distribution to LPs if the overall facility requires repayment first.
LPs should request an illustrative waterfall showing how proceeds from a hypothetical exit would be applied: first to NAV lenders, then to fees, then to LPs and the GP. Comparing that waterfall with and without the NAV facility makes the capital structure transparent.
Valuation and LTV: Sensitivity of NAV Loans to Marks
NAV lending rests on GP-reported net asset value. That makes valuation methodology a core risk point. Risks associated with NAV loans include increased leverage and valuation challenges, and NAV financing can distort performance metrics reported to investors.
LTV ratios at closing may look comfortable, but NAV is not static. Periodic revaluations (quarterly or semi-annual) test whether LTV remains within covenant thresholds, whether concentration limits are respected, and whether the portfolio still meets quality tests. If net asset value declines beyond agreed thresholds, the consequences can include mandatory prepayments, distribution blocks, or in severe cases, acceleration of the loan.
Valuation governance matters. ILPA's 2024 guidance recommends that advisory boards or limited partner advisory committee members review valuation methodology, that independent valuation agents or auditors be involved, and that GPs disclose any changes to valuation approaches used as the basis for NAV based facilities. These are recommendations, not binding legal requirements, but they set a useful benchmark.
LPs should run simple scenario analyses. Model what happens if NAV drops 20% or 30%: how quickly do LTV covenants bind, are distributions blocked, and how much equity value remains after debt repayment? For portfolios concentrated in a few prized assets, even modest markdowns can trigger covenant stress.
Pricing, Interest and Fees: Understanding the True Cost
NAV loan pricing typically involves a base rate (SOFR, Euribor, or equivalent) plus a margin, along with arrangement fees, commitment fees, original issue discount, and sometimes prepayment penalties. Margins vary by strategy, portfolio diversification, lender type, and leverage level. NAV loans add a layer of debt, increasing overall financial risk, and the cost of that debt reduces net proceeds available to LPs.
A key distinction is between cash-pay interest and payment-in-kind (PIK) interest. Cash-pay interest requires regular outflows from the fund. PIK interest capitalizes unpaid interest into the loan balance, deferring the cash burden but growing the outstanding debt over time. In a declining-NAV scenario, PIK can tighten leverage ratios faster than expected.
NAV loans can enhance internal rate of return for investors in certain scenarios by accelerating the timing of cash flows. But fees and break costs can materially erode net proceeds, especially for shorter-dated facilities or partial drawdowns. LPs should ask whether interest and fees are borne solely by the borrowing fund, shared across parallel vehicles, or allocated to continuation or co-investment funds.
Covenants, Triggers and Restrictions on LP Distributions
Covenants in NAV lending agreements are ongoing promises related to LTV limits, portfolio quality and concentration tests, valuation methodology, and reporting obligations. They function as guardrails, but when breached, they can restrict what LPs receive.
Distribution blockers prevent or restrict cash distributions to limited partners when certain leverage or coverage thresholds are breached. NAV loans can enhance LP capital return timing when covenants are satisfied and markets cooperate. NAV loans can also protect LPs from fire-sale discounts by allowing the fund to hold assets longer. But if covenants tighten, the same facility that was meant to provide a liquidity bridge can lock up cash flows entirely.
Common default triggers include payment defaults, material adverse changes in portfolio value, unauthorized changes in investment strategy or policy, and violations of negative covenants such as prohibitions on additional fund level debt or unauthorized asset sales.
LPs face risks of recallable distributions from NAV loans. If the facility permits distributions funded by further borrowing rather than only from realizations in excess of required debt service, that increases risk. LPs should seek copies or detailed summaries of covenant packages, including any springing liens, cash sweeps, or restrictions on recycling and recall rights.
Borrowed Distributions: Why They Don't Prove Performance
Cash distributions funded by NAV loans are not equivalent to realized gains. This is perhaps the single most important point for passive investors in private equity to understand.
Illustrative hypothetical (labeled as such, not predictive): A fund has a NAV of $500 million. It takes a NAV loan of $50 million at 10% LTV and distributes that cash to LPs. The DPI ratio rises. But the underlying portfolio remains unrealized. Future exits must repay the $50 million loan plus accumulated interest and fees before any additional proceeds flow to LPs. If those future realizations underperform expectations, the net return to LPs could be lower than the interim metrics suggested.
NAV loans can create artificial liquidity, impacting long-term returns. Investors may push back against NAV loans used solely for fund distributions. NAV loans can improve fund performance metrics for LPs in the near term, but those metrics reflect borrowed cash, not asset sales or value realization.
Borrowed cash can also accelerate carry crystallization. If cumulative distributions (including debt-funded ones) push the fund past a carried interest hurdle, the GP may begin receiving carry earlier than if distributions were strictly from realized proceeds. Without robust clawback or escrow mechanics, this can misalign incentives.
LPs should ask fund managers to distinguish, in every quarterly report, between distributions sourced from realizations, from recycling, and from fund-level borrowings. Requesting metrics "net of NAV-financed distributions" reveals what the portfolio is actually producing.
Conflicts of Interest and Alignment Between GPs and LPs
NAV loans can create conflicts of interest between general partners and limited partners. The most common agency issues include pressure to maintain high valuations to avoid covenant breaches, temptation to delay exits so that unrealized portfolio value keeps the borrowing base intact, and incentives to use NAV financing to enhance short-term return metrics rather than maximize long-term outcomes.
NAV loans may increase agency costs for LPs. Carried interest mechanics deserve particular scrutiny. If borrowing to fund distributions allows a GP to reach carry thresholds earlier, and if clawback provisions are weak or escrow accounts are undersized, the GP benefits at LP expense. NAV loans can complicate fund structures and disadvantage limited partners, especially in structures involving multiple funds, continuation vehicles, or co-investment vehicles where one set of portfolio assets supports several capital structures.
Excessive reliance on NAV loans can amplify investor losses during financial stress. ILPA's 2024 guidance recommends that GPs disclose the rationale for entering a NAV facility, alternatives considered (such as asset sales, secondary sales, or additional capital calls), and the expected impact on risk and return before proceeding. LPs should evaluate whether the GP's own capital and fee structures are similarly exposed to the risks the NAV loan creates. If the GP's carried interest and management fees are insulated from downside while LP distributions depend on successful repayment of fund level debt, alignment is weak.
Reporting, Transparency and ILPA's NAV Financing Guidance
The Institutional Limited Partners Association issued guidelines for NAV-based lending in 2024, specifically addressing private equity strategies. These are industry recommendations, not binding law or a substitute for LP contractual rights. ILPA emphasizes the importance of transparency in NAV loan usage and recommends transparency in NAV loan usage and disclosures.
ILPA's core reporting recommendations include:
- Clear use-of-proceeds disclosure
- Facility size, LTV, maturity, interest rate, and fee details
- Description of collateral and concentration risk
- Covenant summaries, distribution blockers, and default triggers
- Impact analysis on LP distributions and risk under base and stressed scenarios
Proper governance and transparency are recommended when using NAV financing. ILPA advises GPs to seek LPAC approval for NAV loans, particularly when proceeds are used for distributions.
LPs' actual rights depend on their limited partnership agreements, side letters, and applicable law. Some LPAs explicitly address NAV facilities; many do not. Where the LPA is silent, ILPA recommends that GPs voluntarily seek limited partner advisory committee consent. LPs should request reporting that breaks out performance with and without the effect of NAV leverage. Sophisticated institutional investors, along with other institutional investors, should coordinate through LPACs or advisory committees to review proposals against both ILPA guidance and fund documents.
Key Diligence Questions to Ask a GP About NAV Loans
The following questions can be adapted into LP diligence memos. They are not legal advice.
Rationale and alternatives:
- Why is NAV financing preferable to other options for this asset class, such as asset sales, private equity secondaries market transactions, or additional capital calls?
- What investment strategies or portfolio circumstances make this facility appropriate now?
- What is the expected impact on the fund's internal rate of return and on distributions to paid in capital?
Structure and risk:
- What is the maximum LTV at closing and under the facility agreement?
- Which portfolio companies or fund interests are pledged? How diversified is the collateral pool?
- What is the tenor, amortization schedule, and mandatory prepayment structure?
- What scenarios would trigger restrictions on LP distributions?
Economics and alignment:
- What is the interest margin, and is interest cash-pay or PIK?
- How are fees allocated among parallel vehicles or continuation funds?
- Does this transaction accelerate or defer GP carry? What clawback or escrow protections exist?
Governance and reporting:
- What approvals have been obtained from the limited partner advisory committee?
- What ongoing reporting will LPs receive on the facility, including covenant compliance?
- Can you provide disclosure consistent with ILPA's 2024 NAV guidance?
- Will you report distributions separately by source (realizations, recycling, NAV borrowings)?
Document-Request Checklist for LPs Reviewing NAV Facilities
LPs reviewing a proposed or existing NAV facility should request the following documents and review them with counsel:
- Loan agreement: executed or draft NAV loan agreement, including amendments and ancillary documents
- Security documents: pledge agreements over equity interests, distribution rights, receivables, and any SPV organizational documents
- Intercreditor agreements: particularly if subscription lines, other fund level debt, or credit facilities exist alongside the NAV loan
- Lender side letters: any related agreements between the GP and NAV lenders affecting fund interests or parallel vehicles
- LPA excerpts: provisions covering borrowing limits, permitted debt financing, and any clauses that explicitly address NAV facilities
- LPAC materials: minutes or resolutions approving the NAV loan, and any written rationale provided by the GP
- Financial projections: scenario analyses showing the impact of the facility on cash flows to LPs and expected fund life under base, moderate, and severe downside assumptions
- Legal and tax memos: opinions from the GP's counsel outlining material consequences of pledging equity in portfolio companies, including jurisdictional, reporting, and withholding considerations
This is a document checklist, not legal drafting advice. The purpose is to ensure LPs have sufficient information to evaluate the facility alongside their own advisors.
Risk, Liquidity and Scenario Analysis for Institutional Investors
NAV loans affect risk and liquidity in several ways. More leverage at the fund level means more sensitivity to downturns. Near-term distributions may be smoother, but they come at the cost of reduced cushion if the private equity market weakens. The NAV lending market has grown rapidly, and the tools available to private equity managers and asset managers have expanded, but the underlying risk dynamics of leverage have not changed.
LPs should consider their own liquidity needs, capital call obligations, and exposure across multiple funds and asset classes when assessing NAV lending proposals. In stressed environments, a distribution blocker triggered by a covenant breach in one fund can affect an LP's cash flow planning across their entire portfolio of direct investments and investment funds.
Simple scenario testing is valuable:
- Base case: stable NAV, modest growth, LTV well within covenants, distributions flow after debt service
- Moderate downturn: NAV declines 20–30%, LTV approaches thresholds, cash sweeps or distribution blockers activate, mandatory prepayments reduce available capital
- Severe downturn: NAV falls beyond cushion, covenant breach, potential default or forced restructuring, residual equity value for LPs diminished
NAV lending can interact with other fund-level tools. Recycling provisions, continuation vehicles, and secondary sales all shape eventual cash flows. A GP using a NAV facility to seed a continuation vehicle, for example, is not delivering a traditional exit. The LP needs to understand whether proceeds represent genuine realizations or transfers between vehicles managed by the same private equity firms.
NAV loans are one tool among many in portfolio management. They can serve legitimate purposes in the private equity industry when used with discipline and transparency. The LP's job is to understand whether that tool is being used to create value or to create appearances. Venture capital, hedge funds, public companies, and other corners of the investment landscape all use leverage, but in private markets the opacity of valuations and the illiquidity of underlying assets make diligence more consequential.
How 506 Investor Group Members Compare Diligence Notes
Sophisticated accredited investors and qualified purchasers in the 506 Investor Group share NAV financing diligence questions, term sheet expectations, and LPAC experiences with each other, not with sponsors or capital raisers. Members often benchmark GP responses on NAV loan proposals against those from other private equity, buyout funds, and real asset funds to calibrate what is market-standard and what is aggressive.
The group's existing guides on private equity for qualified purchasers and reading PE performance metrics can be used alongside this NAV loan checklist to evaluate fund level debt in context. Comparing notes with other passive investors when evaluating complex NAV based facilities helps establish norms and avoids being surprised by uncommon or aggressive terms.